— Know what they know.
Not Investment Advice
Also trades as: 0HF3.L (LSE) · $vol 0M

COR NYSE

Cencora, Inc.
1W: -2.9% 1M: +7.6% 3M: +3.4% YTD: -2.4% 1Y: +0.7% 3Y: +77.3% 5Y: +186.0%
$327.48
-2.52 (-0.76%)
 
Weekly Expected Move ±3.1%
$310 $321 $331 $341 $352
NYSE · Healthcare · Medical - Distribution · Tech Score Buy · Power 73 · $63.0B mcap · 180M float · 0.776% daily turnover · Short 34% of daily vol
Credit Risk of going bust: lower than 74% of companies Debt: 15.7% of company value Bonds: $362.8M held by 313 funds, 60 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $4.32 (down 99%), Cencora, Inc. would be worth roughly what it owes.
Total debt $11.72B against a stock market value of $62.97B.
Distance to default 8.23 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $6.00B (short-term plus half of long-term), stock volatility 32.3%; Altman Z'' 0.42. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Smart Money Score
Bullish 100
Insider+$2.3M
Congress1 trades
ETF Holdings—
Key Statistics
Market Cap$63.0B
52W Range244.82-377.54
Volume993,467
Avg Volume1,398,531
Beta0.58
Dividend$2.40
Analyst Ratings
33 Buy 12 Hold 1 Sell
Consensus Buy
Company Info
CEORobert Mauch
Employees49,000
SectorHealthcare
IndustryMedical - Distribution
IPO Date1995-04-04
1 West First Avenue
Conshohocken, PA 19428-1800
US
610 727 7000
About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Recent Insider Trades

NameTypeSharesPriceDate
Krikorian Lazarus S-Sale 986 $303.18 2026-10-01
SANCHEZ ROBERT E A-Award 275 — 2026-10-01
SANCHEZ ROBERT E 0 — 2026-10-01
GREENBERG LON R S-Sale 1,280 $321.30 2026-09-16
Krikorian Lazarus S-Sale 985 $325.97 2026-09-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms